Skip to content
AKAVA THERAPEUTICS
  • About Us
    • Management Team
    • Scientific Advisory Board
    • Board of Directors
  • Pipeline
    • Protein Aggregation Inhibitor
    • Ornithine Aminotransferase Inactivator
    • Neuronal Nitric Oxide Synthase Inhibitors
  • Therapeutic Areas
  • Science
    Behind the Discoveries
    • AKV9, Protein Aggregation Inhibitor
    • What Makes AKV9 Different?
    • Ornithine Aminotransferase Inactivators
    • Neuronal Nitric Oxide Synthase Inhibitors
  • Partners &
    Collaborators
  • News
  • Publications
  • Careers
  • Contact Us
Menu
  •          
  • Print

pipeline

Search Results for:

AKAVA THERAPEUTICS > Draw Attention > pipeline
AKAVA THERAPEUTICS > Draw Attention > pipeline
pipeline
  • About Us
  • Pipeline
  • Therapeutic Areas
  • Science Behind the Discoveries
  • Partners & Collaborators
  • News
  • Publications
  • Careers
  • Contact Us
  • Site Map
  • Privacy Policy

AKAVA Therapeutics is developing first-in-class small molecule therapeutics that inhibit protein aggregation, inhibit enzymes and inhibit cancer for a variety of neurodegenerative diseases and cancers.

© Akava Therapeutics. All Rights Reserved
Website by Axxiem
Scroll to top
By accessing our website or software provided by our third-party vendors, you consent to accept cookies, (including other identifiers). These include pieces of text that are stored on your computer or device. This site uses cookies and Google Analytics to improve navigation, minimize the need to reenter information previously entered on forms, personalize messages, and collect statistical information to improve site navigation and provide content of greatest interest to users.Accept